Page 96 - 《中国药房》2025年15期

·药学服务·

咳喘药学服务门诊工作模式构建与效果分析
Δ

＊
李 翔 ，李 颖，汪永忠，夏伦祝（安徽中医药大学第一附属医院药学部，合肥 230031）
#
中图分类号 R969.3 文献标志码 A 文章编号 1001-0408（2025）15-1910-05
DOI 10.6039/j.issn.1001-0408.2025.15.16

摘 要 目的 建立咳喘药学服务门诊工作模式，分析门诊药学服务干预对患者产生的效果。方法 我院开设咳喘药学服务门诊，
建立完善的规章制度，配置完整的软硬件设施，并确定药学服务流程。收集2021年5月－2024年12月就诊患者的基本信息，包括
性别、年龄、居住地和病程等；收集患者就诊和随访时的健康状况、疾病严重程度、吸入剂使用技术和用药依从性等指标，并进行统
计分析，以考察药学服务干预对患者的影响。结果 确立了我院咳喘药学服务门诊服务流程，共收集了 215 例患者的基本信息。
就诊患者中男性占比为 55.35%、平均年龄为（60.91±15.75）岁，60～69 岁患者占比最大（28.37%），用药依从性较差[平均得分为
（5.64±1.76）分]；诊断为慢性阻塞性肺疾病、使用布地奈德福莫特罗粉吸入剂的患者占比最多。68例随访患者中，欧洲五维健康
量表评分上升5.81分（P＜0.05），慢性阻塞性肺疾病评估测试评分下降4.05分（P＜0.05），疾病影响程度减小；哮喘控制测试评分
上升4.80分，达到部分控制水平。吸入剂使用技术评分升高2.31分（P＜0.05），用药依从性评分升高1.09分（P＜0.05），患者满意
度超过90%。结论 经过药学服务干预后，患者的健康状况、疾病严重程度、吸入剂使用技术和用药依从性均有所改善，对咳喘药
学服务门诊满意度较高。咳喘药学服务门诊提供的药学服务干预能改善患者的疾病症状和用药依从性，提高医院合理用药水平。
关键词 咳喘；药学门诊；慢性阻塞性肺疾病；哮喘；药学服务

Construction and effectiveness analysis of working model of cough and asthma pharmaceutical care clinic
LI Xiang，LI Ying，WANG Yongzhong，XIA Lunzhu（Dept. of Pharmacy， the First Affiliated Hospital of Anhui
University of Chinese Medicine， Hefei 230031， China）

ABSTRACT OBJECTIVE To establish a working model for the cough and asthma pharmaceutical care clinic and analyze the
effects of outpatient pharmaceutical care interventions on patients. METHODS A pharmaceutical care clinic for cough and asthma
was established in our hospital， with comprehensive regulations and rules， complete infrastructure and defined pharmaceutical care
workflows. The demographic data of patients （gender， age， residence， disease duration and so on） were collected from May 2021
to December 2024. Indicators including health status， disease severity， inhalation technique， and medication adherence during visits
and follow-up were collected and analyzed statistically， to assess the effects of pharmaceutical care interventions on patients.
RESULTS The service procedure for the cough and asthma pharmaceutical care clinic in our hospital was established. A total of 215
patients’ basic information was collected. It was found that among the patients， males accounted for 55.35%， with an average age
of （60.91±15.75） years old. Patients aged 60 to 69 constituted the largest proportion at 28.37%， and they exhibited relatively poor
medication adherence [with an average score of （5.64±1.76）]. The majority of patients were diagnosed with chronic obstructive
pulmonary disease （COPD） and prescribed budesonide/formoterol powder inhalers. In 68 follow-up cases， EQ-5D-5L scores
increased by 5.81 points （P＜0.05）； COPD Assessment Test （CAT） scores decreased by 4.05 points （P＜0.05）， indicating reduced
disease burden. Asthma Control Test （ACT） scores improved by 4.80 points， reaching partial control levels. Inhaler technique
scores increased by 2.31 points （P＜0.05）. Medication adherence scores rose by 1.09 points （P＜0.05）. Patient satisfaction was
over 90%. CONCLUSIONS After pharmaceutical care intervention， patients’ health status， disease severity， inhalant use
technique， and compliance have all improved， and their satisfaction with the cough and asthma pharmaceutical care outpatient
service is high. The pharmaceutical care intervention provided by the cough and asthma pharmaceutical care outpatient service can
improve patients’ disease symptoms and medication compliance， and enhance the level of safe and rational drug use in the hospital.
KEYWORDS cough and asthma； pharmaceutical clinic； chronic obstructive pulmonary disease； asthma； pharmaceutical care

Δ 基金项目 2024年国家中医药管理局国家中医优势专科建设单 慢性阻塞性肺疾病（chronic obstructive pulmonary
位（临床药学）项目（No.国中医药医政函〔2024〕90号）；安徽省高校科 disease，COPD）和哮喘是临床上常见的慢性肺部疾病，
研计划重点项目（No.2023AH050745） 且发病率和病死率正逐年上升 ，加之这类疾病根治困
[1]
＊第一作者 主管药师。研究方向：临床药学、医院药学。E-mail：
难，容易反复发作，需要长期用药，已成为呼吸内科最常
xiangli0114@163.com
见的疾病类型。2021年全球疾病负担研究（Global Bur‐
# 通信作者 主任药师。研究方向：临床药学、人文药学。电话：
0551-62838556。E-mail：wyzhmail@163.com den of Disease Study 2021，GBD 2021）结果显示，我国

· 1910 · China Pharmacy 2025 Vol. 36 No. 15 中国药房 2025年第36卷第15期